Search clinical trials for: SP-01 (Granisetron Transdermal Delivery System)

Total 40 results

Solasia Pharma K.K.

Completed

Bioequivalence Study in Healthy Chinese Subjects Comparing SP-01 (Granisetron Patch) Manufactured at Two Different Sites

Healthy Volunteers

Hong Kong
Solasia Pharma K.K.
Proswell Medical Corporation

Completed

A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting

Chemotherapy-induced Nausea and Vomiting

China
Fudan University

Recruiting

Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents

Chemotherapy-induced Nausea and Vomiting (CINV)

China
Mylan Technologies Inc.
Mylan Inc.

Active, not recruiting

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Contraception

United States, Canada, Puerto Rico
Prostrakan Pharmaceuticals

Completed

PK, Tolerability and Safety of the co-Administration of Sancuso® (Transdermal Granisetron) and IV Granisetron

Healthy

United Kingdom
Kyowa Kirin Pharmaceutical Development Ltd

Completed

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Chemotherapy Induced Nausea and Vomiting

United States
Mundipharma AB

Completed

A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol

Osteoarthritis

Sweden
Prostrakan Pharmaceuticals

Completed

An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron

Pharmacokinetics

United Kingdom
University of Southern California
National Cancer Institute (NCI)

Terminated

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

Breast Cancer | Nausea | Vomiting

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

Pain

United States
Prostrakan Pharmaceuticals

Completed

Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)

Healthy

United States
Tianjin Medical University Cancer Institute and...

Recruiting

Granisetron Transdermal Patch System for Prevention of CINV by CapeOX

Chemotherapy-induced Nausea and Vomiting

China
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Pain | Cancer

United States
Kyowa Kirin, Inc.
PPD

Completed

Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.

Healthy Volunteers

United States
Altea Therapeutics

Completed

Transdermal Basal Insulin Patch Study in Type 1 Diabetes

Type 1 Diabetes

United States
ZARS Pharma Inc.

Completed

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain

Pain

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy

Chronic Pain
Agile Therapeutics

Completed

Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

Healthy
Agile Therapeutics

Completed

Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females

Healthy

United States
Agile Therapeutics

Completed

Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers

Healthy

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

Pain

United States
Purdue Pharma LP

Completed

Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Osteoarthritis

United States
Purdue Pharma LP

Completed

Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.

Chronic Pain

United States
Purdue Pharma LP

Completed

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

Postoperative Pain

United States
Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.

Back Pain

United States
Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Osteoarthritis

United States
Bayer

Completed

Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch

Hot Flashes
Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

Chronic Low Back Pain

United States
University of Illinois at Chicago

Recruiting

BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

Chemotherapy-induced Nausea and Vomiting

United States
Agile Therapeutics

Completed

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches (ATI-CL21)

Healthy
Massachusetts General Hospital

Withdrawn

Butrans for Treatment of Restless Legs Syndrome (Butrans)

Restless Legs Syndrome

United States
Watson Pharmaceuticals

Completed

Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder (MATRIX)

Quality of Life | Overactive Bladder | Urinary Incontinence

United States
Fudan University

Not yet recruiting

Granisetron Transdermal Patch for Prophylaxis of Delayed CINV

Chemotherapy-induced Nausea and Vomiting (CINV)
Janssen-Cilag Ltd.

Completed

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

Cancer, Pain
Gelderse Vallei Hospital
Wageningen University; Deventer Ziekenhuis

Completed

Nicotine Replacement Therapy in the Intensive Care Unit (NicGoWell)

Delirium | Psychomotor Agitation | Substance Withdrawal Syndrome | Nicotine Replacement Therapy

Netherlands
Agile Therapeutics

Completed

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm (ATI-CL13)

Contraception

United States
Khon Kaen University

Completed

Transdermal Fentanyl Patch for Postoperative Analgesia After Abdominal Surgery: a Randomized Placebo-controlled Trial

Postoperative Pain Relief

Thailand
The University of Texas Health Science Center,...
ZARS Pharma Inc.

Unknown

In Children, Does Using a Synera Patch Decrease Pain When Injecting Propofol at Anesthesia Induction? (Synera patch)

Pain on Propofol IV Injection

United States
The University of Texas Health Science Center,...

Completed

Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection

Pain on IV Injection of Propofol.

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Nausea and Vomiting | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Stage IIA Fallopian Tube Cancer | Stage... and other conditions

United States

3

Subscribe